Related Experiment Video
Updated: Jun 16, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Smoking in primary headaches - a systematic review and meta-analysis.
Bartłomiej Błaszczyk1, Helena Martynowicz2, Jakub Przegrałek3
1Department of Neurology, Wroclaw Medical University, Wroclaw, Poland. jannazwa@gmail.com.
Current cigarette smoking increases migraine risk but decreases tension-type headache risk. No link was found for cluster headaches, despite high smoking rates in patients.
Area of Science:
- Neurology
- Public Health
- Epidemiology
Background:
- Primary headaches include migraine, tension-type headache (TTH), and cluster headache (CH).
- Existing research on smoking and primary headaches presents conflicting findings.
- This study investigates the association between smoking and primary headaches.
Purpose of the Study:
- To evaluate the prevalence and association between smoking and primary headaches.
- To synthesize current evidence on smoking's impact on migraine, TTH, and CH.
Main Methods:
- Systematic review adhering to PRISMA 2020 guidelines.
- Searched PubMed and Scopus databases up to February 2025.
- Included 37 studies in a meta-analysis, assessing bias with the Joanna Briggs Institute tool.
Main Results:
- Current smoking linked to increased migraine risk (OR=1.29) and decreased TTH risk (OR=0.78).
- Prevalence of smoking was 20% in migraine, 19% in TTH, and 65% in CH.
- No significant association found between current smoking and cluster headaches or migraine with aura.
Conclusions:
- Current smoking is associated with higher migraine incidence and lower TTH incidence.
- Despite high prevalence, current smoking shows no association with cluster headaches.
- The impact of newer nicotine products like e-cigarettes on primary headaches remains unexamined.
More Related Videos
Related Concept Videos
Stress Prevention and Stress Management Techniques IV
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Criteria for Causality: Bradford Hill Criteria - II
Chronic Obstructive Pulmonary Disease II: Emphysema

